PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34489184-8	2021	Treatment with L-carnitine + Co Q10 ameliorated cognitive impairment and oxidative stress, decreased the brain contents of inflammatory mediators; TNF-alpha, IL-6, and NF-kappabeta elevated AMPK and AKT, as compared to each drug.	Carnitine	15-26	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	190-194	
34489184-0	2021	L-carnitine and Co Q10 ameliorate potassium dichromate -induced acute brain injury in rats targeting AMPK/AKT/NF-kappabeta.	Carnitine	0-11	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	101-105	
34489184-10	2021	L-carnitine + Co Q10 play important role in AMPK/AKT/NF-kappabeta pathway that responsible for their antioxidant and anti-inflammatory effects against PD-induced brain injury in rats.	Carnitine	0-11	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	44-48	
30644033-0	2019	Carnitine Supplementation Attenuates Sunitinib-Induced Inhibition of AMP-Activated Protein Kinase Downstream Signals in Cardiac Tissues.	Carnitine	0-9	protein kinase AMP-activated catalytic subunit alpha 2	Rattus norvegicus	69-97